Sample size and power for cost-effectiveness analysis (part 1)
- PMID: 21309615
- DOI: 10.2165/11585070-000000000-00000
Sample size and power for cost-effectiveness analysis (part 1)
Abstract
Basic sample size and power formulae for cost-effectiveness analysis have been established in the literature. These formulae are reviewed and the similarities and differences between sample size and power for cost-effectiveness analysis and for the analysis of other continuous variables such as changes in blood pressure or weight are described. The types of sample size and power tables that are commonly calculated for cost-effectiveness analysis are also described and the impact of varying the assumed parameter values on the resulting sample size and power estimates is discussed. Finally, the way in which the data for these calculations may be derived are discussed.
Similar articles
-
Power and sample size calculations for stochastic cost-effectiveness analysis.Med Decis Making. 1998 Apr-Jun;18(2 Suppl):S81-92. doi: 10.1177/0272989X98018002S10. Med Decis Making. 1998. PMID: 9566469
-
Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group.BMC Med Res Methodol. 2023 Aug 3;23(1):179. doi: 10.1186/s12874-023-01956-y. BMC Med Res Methodol. 2023. PMID: 37537545 Free PMC article.
-
Power and sample assessments for tests of hypotheses on cost-effectiveness ratios.Health Econ. 2000 Apr;9(3):227-34. doi: 10.1002/(sici)1099-1050(200004)9:3<227::aid-hec509>3.0.co;2-z. Health Econ. 2000. PMID: 10790701
-
Power and sample size for cost-effectiveness analysis: fFN neonatal screening.Contemp Clin Trials. 2011 Nov;32(6):893-901. doi: 10.1016/j.cct.2011.07.007. Epub 2011 Jul 18. Contemp Clin Trials. 2011. PMID: 21782976 Review.
-
Formulae and tables for the determination of sample sizes and power in clinical trials for testing differences in proportions for the two-sample design: a review.Stat Med. 1996 Jan 15;15(1):1-21. doi: 10.1002/(SICI)1097-0258(19960115)15:1<1::AID-SIM134>3.0.CO;2-E. Stat Med. 1996. PMID: 8614740 Review.
Cited by
-
Cost-effectiveness analysis of coronary arteries bypass grafting (CABG) and percutaneous coronary intervention (PCI) through drug stent in iran: a comparative study.Cost Eff Resour Alloc. 2023 Feb 15;21(1):16. doi: 10.1186/s12962-023-00426-y. Cost Eff Resour Alloc. 2023. PMID: 36793078 Free PMC article.
-
A culturally adapted lifestyle intervention addressing a Middle Eastern immigrant population at risk of diabetes, the MEDIM (impact of Migration and Ethnicity on Diabetes In Malmö): study protocol for a randomized controlled trial.Trials. 2013 Sep 3;14:279. doi: 10.1186/1745-6215-14-279. Trials. 2013. PMID: 24006857 Free PMC article. Clinical Trial.
-
Randomised, prospective, medico-economic nationwide French study of islet transplantation in patients with severely unstable type 1 diabetes: the STABILOT study protocol.BMJ Open. 2017 Feb 20;7(2):e013434. doi: 10.1136/bmjopen-2016-013434. BMJ Open. 2017. PMID: 28219959 Free PMC article. Clinical Trial.
-
Cost-effectiveness of point-of-care viscoelastic haemostatic assays in the management of bleeding during cardiac surgery: protocol for a prospective multicentre pragmatic study with stepped-wedge cluster randomised controlled design and 1-year follow-up (the IMOTEC study).BMJ Open. 2019 Nov 5;9(11):e029751. doi: 10.1136/bmjopen-2019-029751. BMJ Open. 2019. PMID: 31694845 Free PMC article.
-
Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up.PLoS One. 2021 Nov 12;16(11):e0259493. doi: 10.1371/journal.pone.0259493. eCollection 2021. PLoS One. 2021. PMID: 34767575 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources